|
Volumn 299, Issue 16, 2008, Pages 1899-
|
Antipsychotic-induced weight gain in patients with schizophrenia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METFORMIN;
NEUROLEPTIC AGENT;
SOMATOMEDIN C;
ANTIDIABETIC AGENT;
CLINICAL TRIAL;
COGNITION;
DRUG MECHANISM;
ENERGY BALANCE;
EXERCISE;
HUMAN;
INSULIN RESISTANCE;
LETTER;
LIFESTYLE MODIFICATION;
NONHUMAN;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SIDE EFFECT;
WEIGHT GAIN;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
METABOLISM;
NOTE;
OBESITY;
PHYSIOLOGY;
RISK REDUCTION;
ANTIPSYCHOTIC AGENTS;
EXERCISE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN RESISTANCE;
INSULIN-LIKE GROWTH FACTOR I;
METFORMIN;
OVERWEIGHT;
RISK REDUCTION BEHAVIOR;
SCHIZOPHRENIA;
WEIGHT GAIN;
|
EID: 42449152832
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.299.16.1899-a Document Type: Letter |
Times cited : (2)
|
References (5)
|